Antizar-Ladislao B, Turrion-Gomez JL (2008) Second-generation biofuels and local bioenergy systems. Biofuels, Bioproducts and Biorefining 2:455–469CrossRefGoogle Scholar
Aono R (1998) Improvement of organic solvent tolerance level of Escherichia coli by overexpression of stress-responsive genes. Extremophiles 2:239–248CrossRefGoogle Scholar
Aono R, Kobayashi H, Joblin KN, Horikoshi K (1994) Efects of organic solvents on growth of Escherichia coli K-12. Biosci Biotechnol Biochem 58:2009–2014CrossRefGoogle Scholar
Atsumi S, Liao JC (2008) Metabolic engineering for advanced biofuels production from Escherichia coli. Curr Opin Biotechnol 19:414–419CrossRefGoogle Scholar
Atsumi S, Cann AF, Connor MR, Shen RC, Simth KM, Brynildsen MP, Chou KC, Hanai T, Liao JC (2008a) Metabolic engineering of Escherichia coli for 1-butanol production. Metab Eng 10:305–311CrossRefGoogle Scholar
Atsumi S, Hanai T, Liao JC (2008b) Non-fermentative pathways for synthesis of branched-chain higher alcohols as biofuels. Nature 451:86–89CrossRefGoogle Scholar
Barak Z, Chipman DM, Gollop N (1987) Physiological implications of the specificity of acetohydroxy acid synthase isozymes of enteric bacteria. J Bacteriol 169:3750–3756Google Scholar
Boulton RB, Singleton VI, Bisson IF, Kunkee RE (1996) Principles and practices of winemaking. Chapman & Hall, Davis, pp 102–181Google Scholar
Cann AF, Liao JC (2008) Production of 2-methyl-1-butanol in engineered Escherichia coli. Appl Microbiol Biotechnol 81:89–98CrossRefGoogle Scholar
Connor MR, Liao JC (2008) Engineering Escherichia coli for the production of 3-methyl-1-butanol. Appl Environ Microbiol 74:5769–5775CrossRefGoogle Scholar
Connor MR, Liao JC (2009) Microbial production of advanced transportation fuels in non-natural hosts. Curr Opin Biotechnol 20:307–315CrossRefGoogle Scholar
de la Plaza M, Fernandez de Palencia P, Pelaez C, Requena T (2004) Biochemical and molecular characterization of a-ketoisovalerate decarboxylase, an enzyme involved in the formation of aldehydes from amino acids by Lactococcus lactis. FEMS Microbiol Lett 238:367–374CrossRefGoogle Scholar
Dewick PM (2002) The biosynthesis of C5–C25 terpenoid compounds. Nat Prod Rep 19:181–222CrossRefGoogle Scholar
Dickinson JR, Lanterman MM, Danner DJ, Pearson BM, Sanz P, Harrison SJ, Hewlins MJ (1997) A 13C nuclear magnetic resonance investigation of the metabolism of leucine to isoamyl alcohol in Saccharomyces cerevisiae. J Biol Chem 272:26871–26878CrossRefGoogle Scholar
Dickinson JR, Harrison SJ, Dickinson JA, Hewlins MJ (2000) An investigation of the metabolism of isoleucine to active amyl alcohol in Saccharomyces cerevisiae. J Biol Chem 275:10937–10942CrossRefGoogle Scholar
Eden A, Van Nedervelde L, Drukker M, Benvenisty N, Debourg A (2001) Involvement of branched-chain amino acid aminotransferases in the production of fusel alcohols during fermentation in yeast. Appl Microbiol Biotechnol 55:296–300CrossRefGoogle Scholar
Ehrlich F (1907) Über die Bedingungen der Fuselölbildung und über ihren Zusammenhang mit dem Eiweissaufbau der Hefe. Ber Dtsch Chem Ges 40:1027–1047CrossRefGoogle Scholar
Farmer WR, Liao JC (2000) Improving lycopene production in Escherichia coli by engineering metabolic control. Nat Biotechnol 18:533–537CrossRefGoogle Scholar
Fortman JL, Chhabra S, Mukhopadhyay A, Chou H, Lee TS, Steen E, Keasling JD (2008) Biofuel alternatives to ethanol: pumping the microbial well. Trends Biotechnol 26:375–381CrossRefGoogle Scholar
Fukuda K, Muromachi A, Watanabe M, Asano K, Takasawa S (1993) Mutants producing high concentrations of the flavor components active amylalcohol and normal propanol in Saccharomyces cerevisiae. J Ferment Bioeng 75:288–292CrossRefGoogle Scholar
Gerpen JV (2005) Biodiesel processing and production. Fuel Process Technol 86:1097–1107CrossRefGoogle Scholar
Gershanovskii VS, Zelinskii YG, Lukyanov AV, Pakhomov VP, Zelvenskii YD (1973) Isoamyl alcohol as a raw material for the production of certain drug preparations. Pharm Chem J 7:236–239CrossRefGoogle Scholar
Gollop N, Damri B, Chipman DM, Barak Z (1990) Physiological implications of the substrate specificities of acetohydroxy acid synthases from varied organisms. J Bacteriol 172:3444–3449Google Scholar
Gusyatiner MM, Lunts MG, Koslov YI, Ivanovskaya LV, Voroshilova EB (2002) DNA coding for mutant isopropylmalate synthase l-leucine producing microorganism and method for producing l-leucine. US Patent 6,403,342Google Scholar
Hazelwood LA, Daran JM, van Maris AJ, Pronk JT, Dickinson JR (2008) The Ehrlich pathway for fusel alcohol production: a century of research on Saccharomyces cerevisiae metabolism. Appl Environ Microbiol 74:2259–2266CrossRefGoogle Scholar
Izak P, Schwarz K, Ruth W, Bahl H, Kragl U (2008) Increased productivity of Clostridium acetobutylicum fermentation of acetone, butanol, and ethanol by pervaporation through supported ionic liquid membrane. Appl Microbiol Biotechnol 78:597–602CrossRefGoogle Scholar
Kalscheuer R, Stolting T, Steinbuchel A (2006) Microdiesel: Escherichia coli engineered for fuel production. Microbiology 152:2529–2536CrossRefGoogle Scholar
Kielland-Brandt MC, Petersen JGL, Mikkelsen JD (1979) Mutants in the synthesis of isoleucine in a non-mating, non-sporulating brewing strain of Saccharomyces carlsbergensis. Carlsberg Res Commun 44:27–36CrossRefGoogle Scholar
Lappe P, Hofmann T (2005) Pentanols. In: Pelc H (ed) Ullmann’s encyclopedia of industrial chemistry. Wiley-VCH, Weinheim, pp 1–14Google Scholar
Lee KH, Park JH, Kim TY, Kim HU, Lee SY (2007) Systems metabolic engineering of Escherichia coli for l-threonine production. Mol Syst Biol 3:149CrossRefGoogle Scholar
Lurton L, Snakkers G, Rodland C, Galy B (1995) Influence of the fermentation yeast strain on the composition of wine spirits. J Sci Food Agric 67:485–491CrossRefGoogle Scholar
Marchionna M, Girolamo MD, Patrini R (2001) Light olefins dimerization to high quality gasoline components. Catal Today 65:397–403CrossRefGoogle Scholar
Martin VJ, Pitera DJ, Withers ST, Newman JD, Keasling JD (2003) Engineering a mevalonate pathway in Escherichia coli for production of terpenoids. Nat Biotechnol 21:796–802CrossRefGoogle Scholar
Mauricio JC, Moreno J, Zea L, Ortega JM, Medina M (1997) The effects of grape must fermentation conditions on volatile alcohols and esters formed by Saccharomyces cerevisiae. J Sci Food Agric 75:155–160CrossRefGoogle Scholar
Morbach S, Sahm H, Eggeling L (1996) l-Isoleucine production with Corynebacterium glutamicum: further flux increase and limitation of export. Appl Environ Microbiol 62:4345–4351Google Scholar
Okolo B, Johnston JR, Berry DR (1987) Toxicity of ethanol, n-butanol and iso-amyl alcohol in Saccharomyces cerevisiae when supplied separately and in mixtures. Biotechnol Lett 9:431–434CrossRefGoogle Scholar
Roffler SR, Blanch HW, Wilke CR (1987) In-situ recovery of butanol during fermentation. Part 1: batch extractive fermentation. Bioprocess Engineering 2:1–12CrossRefGoogle Scholar
Rohdich F, Hecht S, Gartner K, Adam P, Krieger C, Amslinger S, Arigoni D, Bacher A, Eisenreich W (2002) Studies on the nonmevalonate terpene biosynthetic pathway: metabolic role of IspH (LytB) protein. Proc Natl Acad Sci U S A 99:1158–1163CrossRefGoogle Scholar
Salis A, Pinna M, Monduzzi M, Solinas V (2005) Biodiesel production from triolein and short chain alcohols through biocatalysis. J Biotechnol 119:291–299CrossRefGoogle Scholar
Schoondermark-Stolk SA, Tabernero M, Chapman J, Ter Schure EG, Verrips CT, Verkleij AJ, Boonstra J (2005) Bat2p is essential in Saccharomyces cerevisiae for fusel alcohol production on the non-fermentable carbon source ethanol. FEMS Yeast Res 5:757–766CrossRefGoogle Scholar
Sentheshanuganathan S (1960) The mechanism of the formation of higher alcohols from amino acids by Saccharomyces cerevisiae. Biochem J 74:568–576Google Scholar
Shen CR, Liao JC (2008) Metabolic engineering of Escherichia coli for 1-butanol and 1-propanol production via the keto-acid pathways. Metab Eng 10:312–320CrossRefGoogle Scholar
Shimizu E, Oosumi T, Heima H, Tanaka T, Kurashige J, Enei H, Miwa K, Nakamori S (1995) Culture conditions for improvement of l-threonine production using a genetically self-cloned L-threonine hyperproducing strain of Escherichia coli K-12. Biosci Biotechnol Biochem 59:1095–1098CrossRefGoogle Scholar
Sikkema J, de Bont JA, Poolman B (1995) Mechanisms of membrane toxicity of hydrocarbons. Microbiol Rev 59:201–222Google Scholar
Soccol CR, Medeiros ABP, Vandenberghe LPS, Woiciechowski AL (2007) Flavor compounds produced by fungi, yeast, and bacteria. In: Hui YH, Chandan RC, Clark S, Cross N, Dobbs J, Hurst WJ, Nollet LML, Shimoni E, Sinha N, Smith EB, Surapat S, Titchenal A, Toldra F (eds) Handbook of food products manufacturing. Wiley-Interscience, Hoboken, pp 179–191CrossRefGoogle Scholar
Suzzi G, Romano P, Polsinelli M (1998) Isolation and characterization of mutants resistant to amino acid analogues obtained from Saccharomyces cerevisiae strains. World J Microbiol Biotechnol 14:243–246CrossRefGoogle Scholar
The Dow Chemical Company (2002a) 2-Methyl butanol [brochure]. Danbury, Form 327-00038-0405Google Scholar
The Dow Chemical Company (2002b) n-Pentanol [brochure]. Danbury, Form 327-00016-0405Google Scholar
The Dow Chemical Company (2002c) Primary amyl alcohol [brochure]. Danbury, Form 327-00017-0405Google Scholar
Vadali RV, Bennett GN, San KY (2004) Applicability of CoA/acetyl-CoA manipulation system to enhance isoamyl acetate production in Escherichia coli. Metab Eng 6:294–299CrossRefGoogle Scholar
Williams AA, Hollands TA, Tucknott OG (1981) The gas chromatographic–mass spectrometric examination of the volatiles produced by the fermentation of a sucrose solution. Z Lebensm Unters Forsch 172:377–381CrossRefGoogle Scholar
Withers ST, Gottlieb SS, Lieu B, Newman JD, Keasling JD (2007) Identification of isopentenol biosynthetic genes from Bacillus subtilis by a screening method based on isoprenoid precursor toxicity. Appl Environ Microbiol 73:6277–6283CrossRefGoogle Scholar
Zhang K, Sawaya MR, Eisenberg DS, Liao JC (2008) Expanding metabolism for biosynthesis of nonnatural alcohols. Proc Natl Acad Sci U S A 105:20653–20658CrossRefGoogle Scholar
|Molecular structure of 2-methyl-2-butanol|
|2M2B, 2m2b, 2-methyl-2-butanol|
2-Methyl-2-butanol (also known as tert-amyl alcohol or 2M2B) is a tertiary alcohol substance that produces depressant, hypnotic, and anxiolytic effects. Historically, it has been used in anesthesia as a component of avertin fluid mixed with tribromoethanol and water. It has a strong solvent smell reminiscent of gasoline, but with little flavor. 2M2B's simple structure and intoxicating effects have led to its use as a recreational drug.
Fusel alcohols including 2M2B are a grain fermentation by-product and therefore present in many alcoholic beverages. Trace levels of 2M2B have also been detected in various food substances, including fried bacon and cassava, rooibos tea, and fruits (such as apple and pineapple).
2-methyl-2-butanol is also known as tert-amyl-alcohol, 2M2B, or amylene hydrate. 2-methyl-2-butanol is an alcohol with the formula C5H11OH. 2-methyl-2-butanol is comprised of butane, an alkyl chain of four carbons. This chain is substituted at R2 with a methyl group CH3- and an alcohol group OH-. It is synthesized by the reaction of 2-methyl-2-butene with water in the presence of an acid catalyst.
2-Methyl-2-butanol inhibits binding to a proconvulsant site on the GABAreceptor which causes negatively charged chloride ions to enter neurons and increase the amount of excitation necessary to cause the neurons to fire. As it is a tertiary alcohol, it cannot be metabolized by alcohol dehydrogenase into aldehydes (which cause the hangover associated with consuming large amounts of ethanol). This makes 2M2B significantly safer than primary alcohols. However, a consequence of this is that 2-methyl-2-butanol has an extended duration of action with effects which last up to 12 hours after its consumption.
In comparison to other depressants of a similar nature, 2M2B is comparatively closer to alcohol than GHB in terms of its subjective effects and is also considerably more sedating than alcohol but less sedating than GHB.
The effects listed below are based upon the subjective effects index and personal experiences of PsychonautWikicontributors. The listed effects should be taken with a grain of salt and will rarely (if ever) occur all at once, but heavier doses will increase the chances and are more likely to induce a full range of effects. Likewise, adverse effects become much more likely on higher doses and may include serious injury or death.
There are currently no anecdotal reports which describe the effects of this compound within our experience index. Additional experience reports can be found here:
Toxicity and harm potential
The toxicity and long-term health effects of recreational 2M2B use do not seem to have been studied in any scientific context and the exact toxic dosage is unknown although the lowest recorded fatal dose in a human is 30mL. However, 2M2B is expected to be less toxic than ethanol as it cannot be metabolized into aldehydes in the same way. Anecdotal evidence from people who have tried 2M2B within the community suggest that there do not seem to be any negative health effects attributed to simply trying this drug at low to moderate doses by itself and using it sparingly (but nothing can be completely guaranteed).
It is strongly recommended that one use harm reduction practices when using this substance.
Tolerance and addiction potential
As with any other GABA receptor agonist, repeated use and increasing tolerance will eventually result in a withdrawal syndrome upon abrupt discontinuation resembling alcohol, barbiturate, or benzodiazepine withdrawal, up to and including delirium tremens ("the shakes"). The chronic use of this compound can be considered moderately addictive with a high potential for abuse and is capable of causing psychological dependence among certain users. When addiction has developed, cravings and withdrawal effects may occur if a person suddenly stops their usage.
Tolerance to many of the effects of 2M2B develops with prolonged and repeated use. This results in users having to administer increasingly large doses to achieve the same effects. After that, it takes about 3 - 7 days for the tolerance to be reduced to half and 1 - 2 weeks to be back at baseline (in the absence of further consumption). 2M2B presents cross-tolerance with all GABAgenicdepressants, meaning that after the consumption of 2M2B all depressantss will have a reduced effect.
Although many psychoactive substances are safe on their own, they can become dangerous and even life-threatening when combined with other substances. The list below contains some common potentially dangerous combinations, but may not include all of them. Certain combinations may be safe in low doses of each but still increase the potential risk of death. Independent research should always be done to ensure that a combination of two or more substances is safe before consumption.
- Depressants (1,4-Butanediol, 2M2B, alcohol, benzodiazepines, barbiturates, GHB/GBL, methaqualone, opioids) - This combination potentiates the muscle relaxation, amnesia, sedation, and respiratory depression caused by one another. At higher doses, it can lead to a sudden, unexpected loss of consciousness along with a dangerous amount of depressed respiration. There is also an increased risk of vomiting while unconsciousness and dying from the resulting suffocation. If nausea or vomiting occurs before a loss of consciousness, users should attempt to fall asleep in the recovery position or have a friend move them into it.
- Stimulants - It can be dangerous to combine depressants with stimulants due to the risk of accidental excessive intoxication. Stimulants mask the sedative effect of depressants, which is the main factor most people use to gauge their level of intoxication. Once the stimulant effects wear off, the effects of the depressant will significantly increase, leading to intensified disinhibition, motor control loss, and dangerous black-out states. This combination can also potentially result in severe dehydration if one's fluid intake is not closely monitored. If choosing to combine these substances, one should strictly limit themselves to a pre-set schedule of dosing only a certain amount per hour until a maximum threshold has been reached.
This legality section is a stub.
As such, it may contain incomplete or wrong information. You can help by expanding it.
- United Kingdom - It is illegal to produce, supply, or import this drug under the Psychoactive Substance Act, which came into effect on May 26th, 2016.